Prognostic Impact of Non-Cardiac Comorbidities on Long-Term Prognosis in Patients with Reduced and Preserved Ejection Fraction following Acute Myocardial Infarction

Background: We aimed to analyze the prevalence and long-term prognostic impact of non-cardiac comorbidities in patients with reduced preserved left-ventricular ejection fraction (EF) following ST-elevation myocardial infarction (STEMI). Method: A total 3033 STEMI undergoing primary percutaneous coronary intervention (pPCI) were divided two groups: EF < 50% ≥ 50%. The follow-up period was 8 years. Results: Preserved present 1726 (55.4%) 1389 (44.5%) patients. Non-cardiac more frequent compared (38.9% vs. 27.4%, respectively, p 0.001). Lethal outcome registered 240 (17.2%) 40 (2.3%) EF, 0.001. Diabetes chronic kidney disease (CKD) independent predictors for 8-year mortality EF. In CKD independently associated mortality. Conclusion: who had higher than after STEMI. Only diabetes mellitus analyzed